Initial License Fees. In addition to any other license fees payable by Toshiba and SanDisk under Section 5.4 of this Agreement, Toshiba and SanDisk each agree to pay Intermolecular [*] US Dollars (US$[*]) for a cumulative total of [*] US Dollars (US$[*]) for the Intermolecular Background IP license rights set forth in Section 4.1.1 as follows: Intermolecular shall invoice each of Toshiba and SanDisk in the amount of [*] US Dollars (US$[*]) on (a) [*] days following the [*], and (b) [*] days following the [*] anniversary of the [*]. Toshiba and SanDisk each will pay Intermolecular based on such invoices, within [*] days from their respective receipt of such invoices.
Initial License Fees. In consideration for the licenses to the Licensed Patents, Licensed Know-How, and Licensor Improvements, [***] days after the Effective Date, Licensee will pay Licensor a license fee of [***] US Dollars ([***]).
Initial License Fees. Upon payment of the initial license fee specified in -------------------- Schedule 4, and subject to the provisions of Section 2, Distributor shall acquire rights to distribute the Software on that number of Authorized Workstations specified in Schedule 4.
Initial License Fees. A. Initial Financial Institution (one Server) $ ------------- B. Remote Branch Fees
Initial License Fees. In consideration for the licenses to the Licensed Patents, Licensed Know-How, and Licensor Improvements, within [***] days after the Effective Date, Licensee will pay Licensor a license fee of Three Million US Dollars ($3,000,000).
Initial License Fees. (a) The initial License Fees (each an “ILF”) for the Licenses granted under the Original License Order are specified in the following table:
Initial License Fees. In consideration of the rights granted by AFMD to GNE under:
Initial License Fees. For each Accepted Cell Line, BMS shall pay Athersys a license fee of [$*]* (each, an “Initial License Fee”). The Initial License Fees shall be payable within thirty (30) days after the date of acceptance by BMS of the applicable Accepted Cell Line.
Initial License Fees. Astra has made the following non-refundable payments to Millennium in consideration of the rights granted to Astra under this Agreement:
Initial License Fees. In consideration of the rights granted by CG to Kissei under Article 4 (Licenses and Rights) to the Licensed Intellectual Property, Kissei shall pay to CG a one-time-non-refundable-non-creditable-license-fee in the amount of Ten Million US Dollars ($10,000,000). Such payment shall be made within fifteen (15) Business Days after Kissei receives electronic notice from CG of completion of the dosing of the first patient of a full six (6) week treatment in a Phase III Clinical Trial in the United States for a Product and an invoice to Kissei for such payment with bank information.
